Anticipated Shortage

DAPTOMYCIN FOR INJECTION

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DAPTOMYCIN FOR INJECTION in Canada?

A shortage of DAPTOMYCIN FOR INJECTION 500MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 13, 2026), but it has not started yet.

Why is DAPTOMYCIN FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DAPTOMYCIN FOR INJECTION be available again?

The manufacturer's estimated resolution date is November 27, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file2 products

Expected resolution~40 days remaining (estimate)

Affected strength500MG

Report last updated2026-10-13

Checked by MedShort2026-10-17

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DAPTOMYCIN FOR INJECTION RF

EUGIA PHARMA INC.

500MG · DIN 02541920

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

DAPTOMYCIN FOR INJECTION

DR REDDY'S LABORATORIES LTD

500MG · DIN 02490463

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2026-11-27

~40 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02490838

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

DAPTOMYCIN

Tier

Unrated

Last Updated

2026-10-13

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929